The cost of treating Tuberculosis – the role of health economics in TB treatment development

Join us for this webinar with health economics experts to examine TB’s global cost burden to health systems and patients. The webinar will cover the range of costs associated with TB, how we measure these, and the role of health economics within this, particularly how health economics can provide insights into the priorities for new TB treatment development.
This webinar is an introduction to the topic designed for people working in TB or antimicrobial drug development and those with an interest in the health economics of Tuberculosis, including health technology assessment agencies.
This webinar will be the first in a series of three webinars focused on topics related to health economics and TB, hosted by ERA4TB, the National Institute for Health and Care Excellence (NICE), and COMBINE. It will focus on topics related to health economics and TB.

Time:
April 9, 15:00 – 16:00 CEST

Speakers:
Dr Sedona Sweeney
– Associate Professor of Health Economics, LSHTM

Laura Rosu, PhD
– Liverpool School of Tropical Medicine

Moderator:
Katharine Cresswell
– Scientific Adviser at NICE

Register for the webinar by clicking this link or pasting https://limesurvey.biocom.de/index.php/458174?lang=en in the browser.